The Curious Case of MINOCA: Heart Attacks Without Blockages

Heart attacks have long been associated with blocked arteries and traditional risk factors like high cholesterol or obesity. However, a growing number of cases presents a unique challenge to conventional ideology—Myocardial Infarction with Non-Obstructive Coronary Arteries (MINOCA). Unlike typical heart attacks, these cases occur without significant arterial blockage and often affect younger, seemingly healthy individuals. This evolving area of cardiology has significant implications for healthcare practitioners and patients alike.

What is MINOCA?

MINOCA is a term used to describe a heart attack in the absence of obstructive coronary artery disease, typically defined as less than 50% narrowing of the coronary arteries on angiography. It accounts for approximately 5% to 15% of all myocardial infarctions globally. MINOCA is not a disease but rather an umbrella term encompassing multiple underlying mechanisms that lead to ischemic injury.

The most common causes include:

• Coronary Microvascular Dysfunction (CMD): Dysfunction of the heart's small vessels reduces blood flow.
• Coronary Artery Spasm: Temporary constriction of a coronary artery interrupts blood supply.
• Spontaneous Coronary Artery Dissection (SCAD): A tear in the coronary artery wall disrupts blood flow.
• Coronary Embolism or Thrombosis: Clots from other parts of the body travel to the coronary arteries.
• Myocarditis or Inflammatory Causes: Conditions causing inflammation or damage to the heart muscle.

Prevalence and Clinical Insights

A recent Italian study published in the International Journal of Cardiology (2024) examined the differences between MINOCA and Type 2 myocardial infarction (MI) among 7815 NSTEMI patients. The study found that:

• MINOCA accounted for 3.9% of cases compared to 3% for Type 2 MI.
• MINOCA patients were younger and more often female.
• The prognosis for MINOCA patients was better than for Type 2 MI but not without risk, as the composite endpoint (death, non-fatal MI, heart failure, stroke) occurred in 20% of MINOCA patients over a median follow-up of 61 months.

Link to Study Abstract: https://www.internationaljournalofcardiology.com/article/S0167-5273(24)01367-6/abstract

Why MINOCA Matters for Healthcare Practitioners

1. Diagnostic Challenges:

• Many MINOCA cases are missed due to the absence of obstructive coronary artery disease on angiography.
• Advanced imaging, such as cardiac MRI and intravascular ultrasound (IVUS), is critical for identifying underlying causes like SCAD or myocarditis.
• Provocative testing for coronary vasospasm using acetylcholine or ergonovine is underutilized but vital.

2. Diverse Patient Profiles:

• Unlike traditional MIs, MINOCA frequently affects women, particularly postmenopausal women, and younger individuals.
• Many patients lack traditional risk factors, such as diabetes or high cholesterol, complicating risk assessment.

3. Management Nuances:

• Treatment strategies must be tailored to the underlying mechanism:
• Coronary Spasm: Calcium channel blockers (e.g., amlodipine) and nitrates are effective.
• SCAD: Conservative management is preferred unless ischemia persists.
• CMD: ACE inhibitors and beta-blockers may improve microvascular function.
• Traditional therapies like statins and antiplatelets may not always be appropriate.

4. Implications for Public Health in India:

• India’s unique demographic, with a younger population and rising lifestyle-related diseases, necessitates focused research on MINOCA.
• Improving diagnostic awareness and access to advanced testing is critical.

Future Directions in MINOCA Research and Care

• Comprehensive Studies in Diverse Populations:
• Most existing research focuses on Western populations. There is an urgent need for Indian data to understand MINOCA’s prevalence and unique triggers in this region.
• Personalized Treatment Protocols:
• Guidelines for MINOCA are still evolving. Future research should focus on evidence-based therapies tailored to specific etiologies.
• Awareness Among Healthcare Practitioners:
• Cardiologists and emergency physicians need training to recognize and manage MINOCA effectively, especially in younger, seemingly healthy patients.

References and Further Reading

• Aleksova A, et al. "Differences between MINOCA and type 2 myocardial infarction: An ITALIAN observational study." International Journal of Cardiology, 2024. Read the Study: https://www.internationaljournalofcardiology.com/article/S0167-5273(24)01367-6/abstract?
• Sandoval Y, Jaffe AS. "Type 2 myocardial infarction: JACC review topic of the week." J Am Coll Cardiol, 2019;73:1846-1860.
• Reynolds HR, et al. "Myocardial infarction with nonobstructive coronary arteries: A scientific statement from the American Heart Association." Circulation, 2019;139:e891-e908.
• Pasupathy S, et al. "Chest pain characteristics in patients with acute MI without obstructive CAD." J Clin Med, 2023.
• Bakhshi H, Gibson CM. "MINOCA: Myocardial infarction no obstructive coronary artery disease." Am Heart J Plus, 2023;33:100312.